Works matching IS 09509232 AND DT 2007 AND VI 26 AND IP 51

Results: 12

Oncogenic activation of the Met receptor tyrosine kinase fusion protein, Tpr–Met, involves exclusion from the endocytic degradative pathway.

Published in:

Oncogene, 2007, v. 26, n. 51, p. 7213, doi. 10.1038/sj.onc.1210522

By:

Mak, H. H. L.;
Peschard, P.;
Lin, T.;
Naujokas, M. A.;
Zuo, D.;
Park, M.

Publication type:

Article

Mutations of the HIPK2 gene in acute myeloid leukemia and myelodysplastic syndrome impair AML1- and p53-mediated transcription.

Published in:

Oncogene, 2007, v. 26, n. 51, p. 7231, doi. 10.1038/sj.onc.1210523

By:

Li, X.-L.;
Arai, Y.;
Harada, H.;
Shima, Y.;
Yoshida, H.;
Rokudai, S.;
Aikawa, Y.;
Kimura, A.;
Kitabayashi, I.

Publication type:

Article

Comparative expression profiling identifies an in vivo target gene signature with TFAP2B as a mediator of the survival function of PAX3/FKHR.

Published in:

Oncogene, 2007, v. 26, n. 51, p. 7267, doi. 10.1038/sj.onc.1210525

By:

Ebauer, M.;
Wachtel, M.;
Niggli, F. K.;
Schäfer, B. W.

Publication type:

Article

Cooperation between JNK1 and JNK2 in activation of p53 apoptotic pathway.

Published in:

Oncogene, 2007, v. 26, n. 51, p. 7222, doi. 10.1038/sj.onc.1210526

By:

Oleinik, N. V.;
Krupenko, N. I.;
Krupenko, S. A.

Publication type:

Article

A role of estrogen/ERα signaling in BRCA1-associated tissue-specific tumor formation.

Published in:

Oncogene, 2007, v. 26, n. 51, p. 7204, doi. 10.1038/sj.onc.1210527

By:

Li, W.;
Xiao, C.;
Vonderhaar, B. K.;
Deng, C.-X.

Publication type:

Article

The p53–Mdm2–HAUSP complex is involved in p53 stabilization by HAUSP.

Published in:

Oncogene, 2007, v. 26, n. 51, p. 7262, doi. 10.1038/sj.onc.1210531

By:

Brooks, C. L.;
Li, M.;
Hu, M.;
Shi, Y.;
Gu, W.

Publication type:

Article

IFN-γ-induced expression of MUC4 in pancreatic cancer cells is mediated by STAT-1 upregulation: a novel mechanism for IFN-γ response.

Published in:

Oncogene, 2007, v. 26, n. 51, p. 7251, doi. 10.1038/sj.onc.1210532

By:

Andrianifahanana, M.;
Singh, A. P.;
Nemos, C.;
Ponnusamy, M. P.;
Moniaux, N.;
Mehta, P. P.;
Varshney, G. C.;
Batra, S. K.

Publication type:

Article

Endoglin inhibits prostate cancer motility via activation of the ALK2-Smad1 pathway.

Published in:

Oncogene, 2007, v. 26, n. 51, p. 7240, doi. 10.1038/sj.onc.1210533

By:

Craft, C. S.;
Romero, D.;
Vary, C. P. H.;
Bergan, R. C.

Publication type:

Article

Inhibition of Hsp90 function by ansamycins causes downregulation of cdc2 and cdc25c and G<sub>2</sub>/M arrest in glioblastoma cell lines.

Published in:

Oncogene, 2007, v. 26, n. 51, p. 7185, doi. 10.1038/sj.onc.1210534

By:

García-Morales, P.;
Carrasco-García, E.;
Ruiz-Rico, P.;
Martínez-Mira, R.;
Menéndez-Gutiérrez, M. P.;
Ferragut, J. A.;
Saceda, M.;
Martínez-Lacaci, I.

Publication type:

Article

The VEGF angiogenic switch of fibroblasts is regulated by MMP-7 from cancer cells.

Published in:

Oncogene, 2007, v. 26, n. 51, p. 7194, doi. 10.1038/sj.onc.1210535

By:

Ito, T.-K.;
Ishii, G.;
Chiba, H.;
Ochiai, A.

Publication type:

Article

Cyclin B2 suppresses mitotic failure and DNA re-replication in human somatic cells knocked down for both cyclins B1 and B2.

Published in:

Oncogene, 2007, v. 26, n. 51, p. 7175, doi. 10.1038/sj.onc.1210539

By:

Bellanger, S.;
de Gramont, A.;
Sobczak-Thépot, J.

Publication type:

Article

HEF1 is a necessary and specific downstream effector of FAK that promotes the migration of glioblastoma cells.

Published in:

2007

By:

Natarajan, M;
Stewart, J E;
Golemis, E A;
Pugacheva, E N;
Alexandropoulos, K;
Cox, B D;
Wang, W;
Grammer, J R;
Gladson, C L

Publication type:

Correction Notice